StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.28−0.01 (-2.67%)

Close on Nov 17, 2026Market cap $6.11MP/E –Yield –

Soligenix price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Soligenix's price to book ratio was 1.0× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.7× to 23.4×, with a median of 2.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×−0.7
2025Dec 31, 20251.7×+0.7
2024Dec 31, 20241.0×−0.8
2023Dec 29, 20231.9×−16.9
2022Dec 30, 202218.8×+16.9
2021Dec 31, 20211.9×−3.3
2020Dec 31, 20205.2×+0.2
2019Dec 31, 20195.0×+3.4
2018Dec 31, 20181.6×−2.5
2017Dec 29, 20174.2×+0.3
2016Dec 30, 20163.9×−11.8
2013Oct 31, 201315.7×+15.2
2012Apr 30, 20120.5×−8.3
2011Jul 29, 20118.8×–

More Soligenix figures

See a number that looks wrong?